nach oben

Erschienen in:

01.12.2022 | Clinical study

Antidepressant-related withdrawal syndrome

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Antidepressants are associated with disproportionate reporting of withdrawal syndrome compared with other drug classes, and there are reporting differences between individual antidepressants, according to findings of a study published in Drug Safety. …

Gastaldon C, et al. Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database Drug Safety : 28 Nov 2022. Available from: URL: https://doi.org/10.1007/s40264-022-01246-4

Titel: Antidepressant-related withdrawal syndrome
Publikationsdatum: 01.12.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-28802-8

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Antidepressant-related withdrawal syndrome

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Tolvaptan

Cetuximab/fluorouracil/platinum complexes

Tobramycin/vancomycin

Methylprednisolone

Clozapine

Sodium-nitroprusside